A trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of liraglutide in obese children aged 7 to 11 years - Trial 2014-004454-34
Access comprehensive clinical trial information for 2014-004454-34 through Pure Global AI's free database. This phase not specified trial is sponsored by Novo Nordisk A/S and is currently status unknown. The study focuses on Obesity.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2014-004454-34
Trial Details
EU Clinical Trials Register • 2014-004454-34
A trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of liraglutide in obese children aged 7 to 11 years
Study Focus
Sponsor & Location
Novo Nordisk A/S
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
- Subjects with secondary causes of childhood obesity (i.e., hypothalamic, genetic or endocrine causes).
ICD-10 Classifications
Obesity
Other obesity
Obesity, unspecified
Obesity due to excess calories
Obesity and other hyperalimentation
Data Source
EU Clinical Trials Register
2014-004454-34
Non-Device Trial